메뉴 건너뛰기




Volumn 37, Issue 9, 2014, Pages 2622-2631

Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: Results from the diabetes prevention program outcomes study

(11)  Perreault, Leigh a   Temprosa, Marinella b   Mather, Kieren J c   Horton, Ed d   Kitabchi, Abbas e   Larkin, Mary f   Montez, Maria G g   Thayer, Debra h   Orchard, Trevor J i   Hamman, Richard F j   Goldberg, Ronald B k  


Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; GLUCOSE; METFORMIN; TROGLITAZONE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; LIPID;

EID: 84906689333     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0656     Document Type: Article
Times cited : (88)

References (49)
  • 1
    • 0036724346 scopus 로고    scopus 로고
    • Preservation of pancreatic beta-Cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in highrisk hispanic women
    • Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-Cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in highrisk hispanic women. Diabetes 2002;51:2796-2803
    • (2002) Diabetes , vol.51 , pp. 2796-2803
    • Buchanan, T.A.1    Xiang, A.H.2    Peters, R.K.3
  • 2
    • 0037097039 scopus 로고    scopus 로고
    • Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial
    • STOP-NIDDM Trial Research Group
    • Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial. Lancet 2002;359:2072-2077
    • (2002) Lancet , vol.359 , pp. 2072-2077
    • Chiasson, J.L.1    Josse, R.G.2    Gomis, R.3    Hanefeld, M.4    Karasik, A.5    Laakso, M.6
  • 3
    • 0025750835 scopus 로고
    • Prevention of type 2 (non-Insulin-Dependent) diabetes mellitus by diet and physical exercise. The 6-Year Malmö feasibility study
    • Eriksson KF, Lindgärde F. Prevention of type 2 (non-Insulin- Dependent) diabetes mellitus by diet and physical exercise. The 6-Year Malmö feasibility study. Diabetologia 1991;34:891-898
    • (1991) Diabetologia , vol.34 , pp. 891-898
    • Eriksson, K.F.1    Lindgärde, F.2
  • 4
    • 33748748206 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomised controlled trial
    • DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators
    • Gerstein HC, Yusuf S, Bosch J, et al.; DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomised controlled trial. Lancet 2006;368:1096-1105
    • (2006) Lancet , vol.368 , pp. 1096-1105
    • Gerstein, H.C.1    Yusuf, S.2    Bosch, J.3
  • 5
    • 0037034257 scopus 로고    scopus 로고
    • Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
    • Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
    • (2002) N Engl J Med , vol.346 , pp. 393-403
    • Knowler, W.C.1    Barrett-Connor, E.2    Fowler, S.E.3
  • 6
    • 1042303480 scopus 로고    scopus 로고
    • XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients
    • Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155-161
    • (2004) Diabetes Care , vol.27 , pp. 155-161
    • Torgerson, J.S.1    Hauptman, J.2    Boldrin, M.N.3    Sjöström, L.4
  • 7
    • 0035799806 scopus 로고    scopus 로고
    • Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance
    • Finnish Diabetes Prevention Study Group
    • Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350
    • (2001) N Engl J Med , vol.344 , pp. 1343-1350
    • Tuomilehto, J.1    Lindström, J.2    Eriksson, J.G.3
  • 8
    • 84862302415 scopus 로고    scopus 로고
    • Effect of regression from prediabetes to normal glucose regulation on long-Term reduction in diabetes risk: Results from the Diabetes Prevention Program Outcomes Study
    • Diabetes Prevention Program Research Group
    • Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE; Diabetes Prevention Program Research Group. Effect of regression from prediabetes to normal glucose regulation on long-Term reduction in diabetes risk: Results from the Diabetes Prevention Program Outcomes Study. Lancet 2012;379:2243-2251
    • (2012) Lancet , vol.379 , pp. 2243-2251
    • Perreault, L.1    Pan, Q.2    Mather, K.J.3    Watson, K.E.4    Hamman, R.F.5    Kahn, S.E.6
  • 9
    • 84862283195 scopus 로고    scopus 로고
    • Is regression to normoglycaemia clinically important?
    • Yakubovich N, Gerstein HC. Is regression to normoglycaemia clinically important? Lancet 2012;379:2216-2218
    • (2012) Lancet , vol.379 , pp. 2216-2218
    • Yakubovich, N.1    Gerstein, H.C.2
  • 10
    • 33846626478 scopus 로고    scopus 로고
    • The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program
    • Diabetes Prevention Program Research Group
    • Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med 2007;24:137-144
    • (2007) Diabet Med , vol.24 , pp. 137-144
  • 11
    • 70449378172 scopus 로고    scopus 로고
    • Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. Population: Implications for diabetes diagnostic thresholds
    • Cheng YJ, Gregg EW, Geiss LS, et al. Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds. Diabetes Care 2009;32:2027-2032
    • (2009) Diabetes Care , vol.32 , pp. 2027-2032
    • Cheng, Y.J.1    Gregg, E.W.2    Geiss, L.S.3
  • 12
    • 77949553029 scopus 로고    scopus 로고
    • Pre-Diabetes and the risk for cardiovascular disease: A systematic review of the evidence
    • Ford ES, Zhao G, Li C. Pre-Diabetes and the risk for cardiovascular disease: A systematic review of the evidence. J Am Coll Cardiol 2010;55: 1310-1317
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1310-1317
    • Ford, E.S.1    Zhao, G.2    Li, C.3
  • 13
    • 44449144074 scopus 로고    scopus 로고
    • Prevalence of polyneuropathy in pre-Diabetes and diabetes is associated with abdominal obesity and macroangiopathy: The MONICA/KORA Augsburg Surveys S2 and S3
    • KORA Study Group
    • Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A; KORA Study Group. Prevalence of polyneuropathy in pre-Diabetes and diabetes is associated with abdominal obesity and macroangiopathy: The MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 2008;31:464-469
    • (2008) Diabetes Care , vol.31 , pp. 464-469
    • Ziegler, D.1    Rathmann, W.2    Dickhaus, T.3    Meisinger, C.4    Mielck, A.5
  • 14
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
    • (1998) Lancet , vol.352 , pp. 837-853
  • 15
    • 58149389215 scopus 로고    scopus 로고
    • Glucose control and vascular complications in veterans with type 2 diabetes
    • VADT Investigators
    • Duckworth W, Abraira C, Moritz T, et al.; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139
    • (2009) N Engl J Med , vol.360 , pp. 129-139
    • Duckworth, W.1    Abraira, C.2    Moritz, T.3
  • 16
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • Action to Control Cardiovascular Risk in Diabetes Study Group
    • Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
    • Gerstein, H.C.1    Miller, M.E.2    Byington, R.P.3
  • 17
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • ADVANCE Collaborative Group
    • Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
    • (2008) N Engl J Med , vol.358 , pp. 2560-2572
    • Patel, A.1    Macmahon, S.2    Chalmers, J.3
  • 18
    • 45249120586 scopus 로고    scopus 로고
    • Effect of pioglitazone on progression of subclinical atherosclerosis in non-Diabetic premenopausal Hispanic women with prior gestational diabetes
    • Xiang AH, Hodis HN, Kawakubo M, et al. Effect of pioglitazone on progression of subclinical atherosclerosis in non-Diabetic premenopausal Hispanic women with prior gestational diabetes. Atherosclerosis 2008;199:207-214
    • (2008) Atherosclerosis , vol.199 , pp. 207-214
    • Xiang, A.H.1    Hodis, H.N.2    Kawakubo, M.3
  • 19
    • 79953232077 scopus 로고    scopus 로고
    • Pioglitazone for diabetes prevention in impaired glucose tolerance
    • ACT NOWStudy
    • DeFronzo RA, Tripathy D, Schwenke DC, et al.; ACT NOWStudy. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med 2011;364:1104-1115
    • (2011) N Engl J Med , vol.364 , pp. 1104-1115
    • Defronzo, R.A.1    Tripathy, D.2    Schwenke, D.C.3
  • 20
    • 0038455703 scopus 로고    scopus 로고
    • Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: The STOP-NIDDM trial
    • STOP-NIDDM Trial Research Group
    • Chiasson JL, Josse RG, Gomis R, HanefeldM, Karasik A, Laakso M; STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: The STOP-NIDDM trial. JAMA 2003;290:486-494
    • (2003) JAMA , vol.290 , pp. 486-494
    • Chiasson, J.L.1    Josse, R.G.2    Gomis, R.3    Hanefeld, M.4    Karasik, A.5    Laakso, M.6
  • 21
    • 78649887273 scopus 로고    scopus 로고
    • Composition and energy harvesting capacity of the gut microbiota: Relationship to diet, obesity and time in mouse models
    • Murphy EF, Cotter PD, Healy S, et al. Composition and energy harvesting capacity of the gut microbiota: Relationship to diet, obesity and time in mouse models. Gut 2010;59:1635-1642
    • (2010) Gut , vol.59 , pp. 1635-1642
    • Murphy, E.F.1    Cotter, P.D.2    Healy, S.3
  • 22
    • 0001810792 scopus 로고
    • Hexokinase of Escherichia coli. Assay of enzyme activity and adaptation to growth in various media
    • Pakoskey AM, Lesher EC, Scott DB. Hexokinase of Escherichia coli. Assay of enzyme activity and adaptation to growth in various media. J Gen Microbiol 1965;38:73-80
    • (1965) J Gen Microbiol , vol.38 , pp. 73-80
    • Pakoskey, A.M.1    Lesher, E.C.2    Scott, D.B.3
  • 23
    • 15944408334 scopus 로고    scopus 로고
    • A burning question: Does an adipokine-Induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes?
    • Tataranni PA, Ortega E. A burning question: Does an adipokine-Induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 2005;54:917-927
    • (2005) Diabetes , vol.54 , pp. 917-927
    • Tataranni, P.A.1    Ortega, E.2
  • 24
    • 0026310514 scopus 로고
    • Prevention of heart disease in general practice: The use of a risk score
    • Wilson A, Morrell J. Prevention of heart disease in general practice: The use of a risk score. Health Trends 1991;23:69-73
    • (1991) Health Trends , vol.23 , pp. 69-73
    • Wilson, A.1    Morrell, J.2
  • 25
    • 39549093148 scopus 로고    scopus 로고
    • General cardiovascular risk profile for use in primary care: The Framingham Heart Study
    • D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008;117:743-753
    • (2008) Circulation , vol.117 , pp. 743-753
    • D'Agostino, Sr.R.B.1    Vasan, R.S.2    Pencina, M.J.3
  • 26
    • 0034945516 scopus 로고    scopus 로고
    • Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation
    • CHD Risk Prediction Group
    • D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 2001;286:180-187
    • (2001) JAMA , vol.286 , pp. 180-187
    • D'Agostino, Sr.R.B.1    Grundy, S.2    Sullivan, L.M.3    Wilson, P.4
  • 27
    • 70449517253 scopus 로고    scopus 로고
    • 10-Year follow-Up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
    • Diabetes Prevention Program Research Group
    • Knowler WC, Fowler SE, Hamman RF, et al.; Diabetes Prevention Program Research Group. 10-Year follow-Up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677-1686
    • (2009) Lancet , vol.374 , pp. 1677-1686
    • Knowler, W.C.1    Fowler, S.E.2    Hamman, R.F.3
  • 28
    • 0033030445 scopus 로고    scopus 로고
    • Design and methods for a clinical trial in the prevention of type 2 diabetes
    • The Diabetes Prevention Program. The Diabetes Prevention Program
    • The Diabetes Prevention Program. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 1999;22:623-634
    • (1999) Diabetes Care , vol.22 , pp. 623-634
  • 31
    • 69549088241 scopus 로고    scopus 로고
    • Regression from prediabetes to normal glucose regulation in the diabetes prevention program
    • Diabetes Prevention Program Research Group
    • Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF; Diabetes Prevention Program Research Group. Regression from prediabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 2009;32:1583-1588
    • (2009) Diabetes Care , vol.32 , pp. 1583-1588
    • Perreault, L.1    Kahn, S.E.2    Christophi, C.A.3    Knowler, W.C.4    Hamman, R.F.5
  • 32
    • 65349089411 scopus 로고    scopus 로고
    • Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: The Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group
    • Diabetes Prevention Program Research Group
    • Goldberg RB, Temprosa M, Haffner S, et al.; Diabetes Prevention Program Research Group. Effect of progression from impaired glucose tolerance to diabetes on cardiovascular risk factors and its amelioration by lifestyle and metformin intervention: The Diabetes Prevention Program randomized trial by the Diabetes Prevention Program Research Group. Diabetes Care 2009; 32:726-732
    • (2009) Diabetes Care , vol.32 , pp. 726-732
    • Goldberg, R.B.1    Temprosa, M.2    Haffner, S.3
  • 33
    • 84871074453 scopus 로고    scopus 로고
    • Long-Term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: A report from the DPPOutcomes Study
    • Diabetes Prevention Program Outcomes Study Research Group
    • Orchard TJ, Temprosa M, Barrett-Connor E, et al.; Diabetes Prevention Program Outcomes Study Research Group. Long-Term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: A report from the DPPOutcomes Study. DiabetMed 2013;30:46-55
    • (2013) DiabetMed , vol.30 , pp. 46-55
    • Orchard, T.J.1    Temprosa, M.2    Barrett-Connor, E.3
  • 34
    • 84893651437 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2014 update: A report from the American Heart Association
    • American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Go AS, Mozaffarian D, Roger VL, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation 2014;129:e28-e292
    • (2014) Circulation , vol.129
    • Go, A.S.1    Mozaffarian, D.2    Roger, V.L.3
  • 35
    • 84903184698 scopus 로고    scopus 로고
    • 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of theAmerican College of Cardiology/American Heart Association Task Force on Practice Guidelines
    • 12 November, [Epub ahead of print]
    • Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of theAmerican College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 12 November 2013 [Epub ahead of print]
    • (2013) Circulation.
    • Stone, N.J.1    Robinson, J.2    Lichtenstein, A.H.3
  • 36
    • 0032560807 scopus 로고    scopus 로고
    • Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
    • Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339: 229-234
    • (1998) N Engl J Med , vol.339 , pp. 229-234
    • Haffner, S.M.1    Lehto, S.2    Rönnemaa, T.3    Pyörälä, K.4    Laakso, M.5
  • 37
    • 0032515775 scopus 로고    scopus 로고
    • Risk factors for coronary artery disease in non-Insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
    • Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-Insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998;316:823-828
    • (1998) BMJ , vol.316 , pp. 823-828
    • Turner, R.C.1    Millns, H.2    Neil, H.A.3
  • 38
    • 84880323061 scopus 로고    scopus 로고
    • Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
    • Look AHEAD Research Group
    • Wing RR, Bolin P, Brancati FL, et al.; Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369:145-154
    • (2013) N Engl J Med , vol.369 , pp. 145-154
    • Wing, R.R.1    Bolin, P.2    Brancati, F.L.3
  • 39
    • 0033760858 scopus 로고    scopus 로고
    • The Diabetes Prevention Program: Baseline characteristics of the randomized cohort
    • The Diabetes Prevention Program Research Group
    • The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. Diabetes Care 2000;23:1619-1629
    • (2000) Diabetes Care , vol.23 , pp. 1619-1629
  • 40
    • 17144389303 scopus 로고    scopus 로고
    • The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program randomized trial
    • Diabetes Prevention Program Research Group
    • Orchard TJ, Temprosa M, Goldberg R, et al.; Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The Diabetes Prevention Program randomized trial. Ann Intern Med 2005;142:611-619
    • (2005) Ann Intern Med , vol.142 , pp. 611-619
    • Orchard, T.J.1    Temprosa, M.2    Goldberg, R.3
  • 41
    • 0026530536 scopus 로고
    • The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the trials of Hypertension prevention, Phase i
    • Trials of Hypertension Prevention, Phase I
    • Trials of Hypertension Prevention, Phase I. The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. JAMA 1992;267:1213-1220
    • (1992) JAMA , vol.267 , pp. 1213-1220
  • 42
    • 0037006994 scopus 로고    scopus 로고
    • Effect of aerobic exercise on blood pressure: A metaanalysis of randomized, controlled trials
    • Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: A metaanalysis of randomized, controlled trials. Ann Intern Med 2002;136:493-503
    • (2002) Ann Intern Med , vol.136 , pp. 493-503
    • Whelton, S.P.1    Chin, A.2    Xin, X.3    He, J.4
  • 43
    • 52149092766 scopus 로고    scopus 로고
    • Effect of weight loss onmarkers of triglyceriderich lipoprotein metabolism in the metabolic syndrome
    • Chan DC, Watts GF, Ng TW, Yamashita S, Barrett PH. Effect of weight loss onmarkers of triglyceriderich lipoprotein metabolism in the metabolic syndrome. Eur J Clin Invest 2008;38:743-751
    • (2008) Eur J Clin Invest , vol.38 , pp. 743-751
    • Chan, D.C.1    Watts, G.F.2    Ng, T.W.3    Yamashita, S.4    Barrett, P.H.5
  • 44
    • 84880283343 scopus 로고    scopus 로고
    • Effects of acute exercise on postprandial triglyceride response after a high-Fat meal in overweight black and white adolescents
    • Lee S, Burns SF,White D, Kuk JL, Arslanian S. Effects of acute exercise on postprandial triglyceride response after a high-Fat meal in overweight black and white adolescents. Int J Obes (Lond) 2013;37:966-971
    • (2013) Int J Obes (Lond) , vol.37 , pp. 966-971
    • Lee, S.1    Burns, S.F.2    White, D.3    Kuk, J.L.4    Arslanian, S.5
  • 45
    • 0027135159 scopus 로고
    • Relative effects of weight loss and dietary fat modification on serum lipid levels in the dietary treatment of obesity
    • Leenen R, van der Kooy K, Meyboom S, Seidell JC, Deurenberg P, Weststrate JA. Relative effects of weight loss and dietary fat modification on serum lipid levels in the dietary treatment of obesity. J Lipid Res 1993;34:2183-2191
    • (1993) J Lipid Res , vol.34 , pp. 2183-2191
    • Leenen, R.1    Van Der Kooy, K.2    Meyboom, S.3    Seidell, J.C.4    Deurenberg, P.5    Weststrate, J.A.6
  • 46
    • 0020611999 scopus 로고
    • Does weight loss cause the exercise-Induced increase in plasma high density lipoproteins?
    • Williams PT, Wood PD, Krauss RM, et al. Does weight loss cause the exercise-Induced increase in plasma high density lipoproteins? Atherosclerosis 1983;47:173-185
    • (1983) Atherosclerosis , vol.47 , pp. 173-185
    • Williams, P.T.1    Wood, P.D.2    Krauss, R.M.3
  • 47
    • 84883291926 scopus 로고    scopus 로고
    • Changes in insulin resistance and HbA1c are related to exercise-Mediated changes in body composition in older adults with type 2 diabetes: Interimoutcomes fromthe GREAT2DO trial
    • Mavros Y, Kay S, Anderberg KA, et al. Changes in insulin resistance and HbA1c are related to exercise-Mediated changes in body composition in older adults with type 2 diabetes: Interimoutcomes fromthe GREAT2DO trial. Diabetes Care 2013;36:2372-2379
    • (2013) Diabetes Care , vol.36 , pp. 2372-2379
    • Mavros, Y.1    Kay, S.2    Anderberg, K.A.3
  • 48
    • 0037035456 scopus 로고    scopus 로고
    • Prevention Conference VI diabetes and cardiovascular disease: Executive summary: Conference proceeding for healthcare professionals from a special writing group of the American Heart Association
    • Grundy SM, Howard B, Smith S Jr, Eckel R, Redberg R, Bonow RO. Prevention Conference VI: Diabetes and cardiovascular disease: Executive summary: Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 2002;105:2231-2239
    • (2002) Circulation , vol.105 , pp. 2231-2239
    • Grundy, S.M.1    Howard, B.2    Smith, Jr.S.3    Eckel, R.4    Redberg, R.5    Bonow, R.O.6
  • 49
    • 84882254968 scopus 로고    scopus 로고
    • The prevalence of meeting A1C blood pressure and LDL goals among people with diabetes 1988-2010
    • Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care 2013;36:2271-2279
    • (2013) Diabetes Care , Issue.36 , pp. 2271-2279
    • Stark Casagrande, S.1    Fradkin, J.E.2    Saydah, S.H.3    Rust, K.F.4    Cowie, C.C.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.